Bortezomib Is Highly Effective For Pure Red Cell Aplasia After ABO-Incompatible Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Khan, Fatima
Linden, Michael A.
Zantek, Nicole D.
Vercellotti, Gregory M.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5495.5495
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5495
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia
    Pepeler, Mehmet Sezgin
    Dagdas, Simten
    Isleyen, Emel
    Katayifci, Gaye
    Kilicarslan, Aydan
    Ozhamam, Esra
    Adakul, Muhammed Talha
    Ozturk, Fahir
    Ceran, Funda
    Ozet, Gulsum
    TURKISH JOURNAL OF HEMATOLOGY, 2024, 41 (04) : 288 - 290
  • [22] Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematropoietic cell transplantation
    Booth, Garrett S.
    Savani, Bipin N.
    Langston, Amelia A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (04) : 701 - 702
  • [23] Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation
    O'Donghaile, Diarmaid
    Kelley, Walter
    Klein, Harvey G.
    Flegel, Willy A.
    TRANSFUSION, 2012, 52 (02) : 456 - 458
  • [24] Pulsed-high-dose dexamethasone as a treatment for pure red cell aplasia following ABO-incompatible allogeneic stem cell transplantation
    Yang, X.
    Levis, M.
    TRANSFUSION MEDICINE, 2014, 24 (04) : 246 - 248
  • [25] Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab
    Wu, Clinton
    Manchen, Pete
    Edelman, Ariela
    Husnain, Muhammad
    Katsanis, Emmanuel
    Fuchs, Deborah
    Stephens, Laura
    Khurana, Sharad
    JOURNAL OF HEMATOLOGY, 2023, 12 (06) : 277 - 282
  • [26] Increased red cell alloirnmunization risk after ABO-incompatible hematopoietic progenitor cell transplantation
    Cserti, C. M.
    Shaz, B. H.
    Uhl, L.
    TRANSFUSION, 2007, 47 (03) : 146A - 146A
  • [27] Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation
    Busca, Alessandro
    Dellacasa, Chiara
    Giaccone, Luisa
    Manetta, Sara
    Biale, Lucia
    Godio, Laura
    Aydin, Semra
    Festuccia, Moreno
    Brunello, Lucia
    Bruno, Benedetto
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (08) : 1765 - 1770
  • [28] No evidence for endothelial cell chimerism after ABO-incompatible allogeneic hematopoietic stem cell transplantation
    Mueller, RJ
    Stussi, G
    Halter, J
    Schanz, U
    Odermatt, B
    Biedermann, B
    Seebach, JD
    XENOTRANSPLANTATION, 2005, 12 (05) : 362 - 362
  • [29] PURE RED-CELL APLASIA OF LONG DURATION AFTER MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION
    VOLIN, L
    RUUTU, T
    ACTA HAEMATOLOGICA, 1990, 84 (04) : 195 - 197
  • [30] Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors
    Hirokawa, Makoto
    Fukuda, Takahiro
    Ohashi, Kazuteru
    Hidaka, Michihiro
    Ichinohe, Tatsuo
    Iwato, Koji
    Kanamori, Heiwa
    Murata, Makoto
    Sakura, Toru
    Imamura, Masahiro
    Adachi, Soichi
    Suzuki, Ritsuro
    Morishima, Yasuo
    Sakamaki, Hisashi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (07) : 1026 - 1032
12345